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A systematic review of the rates of depression in children and adults with high 1 
functioning autism spectrum disorder   2 
Abstract 3 
Accurate population rates of depression can inform allocation of health resources and service 4 
planning, to counter the impact of depression on quality of life and morbidity. A systematic 5 
review of the rates of depression in children and adults with ASD and without intellectual 6 
disability (HF ASD) was conducted. Nineteen studies met inclusion criteria. Reported rates of 7 
depression varied; the reasons for this are discussed including availability of 8 
psychometrically valid and reliable measures of depression for people with HF ASD, and 9 
heterogeneity of study design. Further examination of the phenomenology of depression in 10 
HF ASD linked to the development of psychometrically valid assessment measures would 11 
facilitate epidemiological studies, improve clinical case recognition and inform treatments 12 
and interventions. 13 
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 Introduction 19 
Depression is a potential co-existing condition in people with autism spectrum 20 
disorder (ASD). Some evidence suggests depression may be a secondary consequence of the 21 
social communication difficulties of people with HF ASD, who may experience increased 22 
risk of bullying, and pressures to conform to societal ‘norms’ (APA, 2013; Kelly, Garnett, 23 
Attwood & Peterson, 2008; Whitehouse, Durkin, Jaquet & Ziatas, 2009). Accurate population 24 
rates of depression are important for guiding resource allocation and service development, to 25 
minimize negative effects on quality of life and daily living activities, and reduce the risk of 26 
suicide (Johansson, Carlbring, Heedman, Paxling, & Andersson, 2013; Stewart, Barnard, 27 
Pearson, Hasan & O’Brien, 2006; Williams, O’Conner, Eder & Whitlock, 2009;). However, 28 
accurate epidemiological evidence of rates of depression in people with ASD relative to the 29 
general population is lacking, and to date there are no population wide studies of prevalence 30 
of depression in HF ASD (De la Iglesia & Olivar, 2015; Stewart et al., 2006).  31 
In the United States, the general population prevalence of major depressive disorder 32 
during a 12 month period was 6.7% of adults (n = 9282), and 10.7% of children (Kessler, 33 
Chiu, Demler & Walters, 2005; US Department of Health, NSDUH, 2013). Current rates of 34 
depression in the UK were 3.7% of women and 2.5% of men (n = 6815) (Spiers et al., 2012). 35 
Comparable large scale surveys have not been undertaken with individuals with ASD. 36 
Previous reviews have focused on depression occurrence, presentation, treatment, 37 
measurement, risk factors and psychiatric comorbidity in ASD (De la Iglesia & Olivar, 2015; 38 
Gillberg & Billstedt, 2000; Mannion & Leader, 2013; Tsai, 2014; Matson & Nebel-Schwalm, 39 
2007; Mazzone, Ruta & Reale, 2012; Shtayermman, 2008; Skokauskas & Gallagher, 2009; 40 
Stewart et al., 2006). Previously reported rates of depression have been inconsistent and this 41 
may be due to a number of factors. For example, depression has been suggested to be higher 42 
in individuals with ASD without intellectual disability (HF ASD) (Mazurek & Kanne, 2010; 43 
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Sterling, Dawson, Estes & Greenson, 2008). However, this may be a methodological artefact 44 
or due to diagnostic overshadowing. For example, depression may manifest more 45 
behaviourally in people with intellectual disability (ID) (Hermans & Evenhuis, 2010; 46 
Magnuson & Constantino, 2011).  47 
This review aimed to examine rates of depression in individuals with ASD without ID 48 
(HF ASD). IQ potentially confounds rates of depression, and may contribute to a different 49 
phenomenology in people with ID. Therefore a separate systematic review is needed to 50 
inform clinicians about depression in people with ASD and ID (Magnusen & Constantino, 51 
2011). This review therefore included the following steps: 52 
1. Identification of depression rates in previous studies including adults with HF ASD 53 
2. Assessment of study quality  54 
3. In the context of 1 and 2, make recommendations about future research directions. 55 
Methods 56 
The review was undertaken and results presented in accordance with Preferred 57 
Reporting Items for Systematic Reviews and Meta Analyses guidelines, and registered with 58 
PROSPERO (registration CRD 42014014340). 59 
Inclusion and exclusion criteria  60 
Published articles reporting empirical research and printed in English, were included 61 
if they met the inclusion criteria; resources did not permit translation of articles in other 62 
languages. The inclusion and exclusion criteria are presented in Table 1. Where studies 63 
included people with IQs > 70 and ≤ 70, and the data was not presented separately, these 64 
were excluded unless at least 85% of participants had average range IQ. Studies reporting 65 
current rates of major depressive disorder (MDD) were included in the review. Studies 66 
reporting clinical or severe depression were included in the review if scaled scores used were 67 
specified as a numerical value. Studies on subclinical depression, dysthymia and lifetime 68 
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rates of MDD were not included, facilitating meaningful comparison with general population 69 
prevalence rates of depression. Studies were only included if they used a measure of 70 
depression, a generic measure with a depression subscale, or assessed depression according to 71 
DSM/ICD criteria. For example, studies were excluded if they used the Child Behaviour 72 
Checklist (CBCL), which has anxious/ depressed and withdrawn/ depressed subscales, plus 73 
has some limitations in specificity for case recognition (Gjevik, Sandstad, Andreassen, Myhre 74 
& Sponheim, 2015). No age restrictions were imposed.   75 
Table 1 around here 76 
Information sources 77 
The following electronic databases were searched: MEDLINE, EMBASE, Cinahl, 78 
ERIC and PsycINFO. The reference lists of selected articles identified in the search were 79 
checked for further publications. Searches were carried out in September 2015, and limited to 80 
those published since 1992 when the term Asperger syndrome was defined by WHO; this 81 
review therefore covers the periods of DSM-IV and 5, ICD-9 and 10.  82 
The search terms used in the titles field were: autis*; asperger*; depress*; comorbid*; mood; 83 
psych*. 84 
Study selection 85 
Screening of articles identified in the electronic searches was titles and abstracts, then 86 
full text and completed by SW. Where inclusion was uncertain, the team discussed the article 87 
and reached consensus. 88 
Data extraction 89 
Data were recorded in an extraction form and included: author, country, population, 90 
number of participants, age, depression measure used, IQ, study outcomes and study findings.  91 
Risk of bias  92 
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Within study bias was assessed using criteria adapted from validated tools (Hoy et al., 93 
2012; Munn, Moola, Riitano & Lisy, 2014) (see Table 2), with the aim of highlighting 94 
characteristics with the potential to over or underestimate depression rates (Higgins & Green, 95 
2011). Bias was assessed independently by a second reviewer on 20% of the papers to check 96 
coding reliability; agreement was 79%. Coding for the measurement of bias was discussed 97 
with the wider team, and consensus was reached. 98 
Table 2 around here 99 
Results 100 
Nineteen studies met the inclusion criteria (Figure 1); data extracted on the 101 
characteristics of studies are shown in Table 3. No articles were excluded on grounds of bias. 102 
Given the considerable heterogeneity in study methodology, it was concluded that articles 103 
could not realistically be combined for a meta-analysis to show pooled rates of depression, 104 
therefore a narrative synthesis was used (The Joanna Briggs Institute, 2014).105 
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Figure 1. Summary of the search selection process   106 
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Sample characteristics 152 
Participants were predominately male. Thirteen studies included children and young 153 
adults (<21 years), and in six studies participants were adolescents and adults (age 16 years 154 
and above). 155 
Geographical location  156 
Six studies were from the United States (USA). The remainder were from: the United 157 
Kingdom (UK) (4), Australia (2), Sweden (2), Turkey (1), Finland (1), the Netherlands (1); 158 
one study included data from both France and the UK; and one from both the USA and 159 
Canada. 160 
Design 161 
All studies were cross-sectional or case control apart from four prospective studies 162 
(Cederlund et al 2010; Gillberg et al 2015; Mukkades & Fateh 2010; Mattila et al 2010) and 163 
two using retrospective design (Gadow et al, 2005; Russell et al, 2015). Participants were 164 
recruited from clinical settings (11 studies), ASD support or community groups (4 studies) 165 
and mixed community/ clinical settings (4). 166 
Study topics of investigation 167 
The focus of the studies included: examining psychiatric comorbidity (12 studies), 168 
psychosocial function (4), self and informant report (2) and profiles of depression (1).  169 
Table 3 around here 170 
Risk of bias within studies 171 
The difference in design between studies that may have contributed to variations in 172 
reported rates of depression, are shown in Table 4 and include the following: the majority of 173 
studies recruited small numbers of participants (all fewer than 71), with the exception of 174 
Russell et al. (2015) (n = 474), Salazar et al. (2015) (n =101), and Gadow et al. (2005) (n = 175 
284). A diagnosis of HF ASD was confirmed during the majority of studies, and so risk of 176 
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bias relating to this was low. Twelve studies had some missing detail regarding participants’ 177 
characteristics (e.g. ethnicity, use of medication), and four studies had missing detail on the 178 
recruitment setting (which could have been useful to support generalisability). In four studies 179 
IQ was not measured contemporaneously or was not reported (e.g. with participants described 180 
as ‘high functioning’). 181 
Three studies (Bitsika & Sharpley, 2015; Gadow et al, 2005; Mazefsy et al, 2011) 182 
used measures that have some psychometric evidence for their use with people with ASD, 183 
including the Autism Comorbidity Interview-Present and Lifetime Version (ACI-PL: Leyfer 184 
et al., 2006), the Child and Adolescent Symptom Inventory (CASI: Gadow & Sprafkin, 185 
2010), and the Child Symptom Inventory–4 (CSI-4: Gadow & Sprafkin, 2002). These are 186 
generic measures with a depression subscale. Otherwise, studies used measures of depression 187 
psychometrically validated in the general population, where evidence of psychometric 188 
properties in ASD populations was limited or missing.  189 
Table 4 around here 190 
Measures of depression used 191 
In addition to diagnosis according to ICD-10 criteria the following measures of 192 
depression were used. 193 
Informant report and diagnostic interview 194 
Structured Clinical Interview for DSM-IV (SCID) and Structured Clinical 195 
Interview for DSM-IV Childhood Disorders (Kid-SCID). The SCID (Spitzer et al, 1992) and 196 
Kid-SCID (Hien et al, 1994) are established diagnostic interviews administered to an 197 
individual or child and their parent or carer. Based on DSM-IV criteria their purpose is to 198 
help clinicians make a psychiatric diagnosis across a range of conditions including 199 
depression.      200 
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Schedule for Affective Disorders and Schizophrenia for School-Age Children-201 
Present and Lifetime Version (KSADS-PL). The KSADS-PL (Kaufman et al., 1997) is a 202 
psychometrically established semi-structured clinical interview for children. Developed from 203 
DSM-IV, its purpose is diagnosis of current or lifetime psychiatric disorders, via child or 204 
parent report. 205 
Isle of Wight semi structured interview (IOW). The IOW (Institute of Psychiatry) is a 206 
subject and informant psychiatric interview exploring functioning and behaviour.  207 
Children’s Interview for Psychiatric Symptoms (P-ChIPS). The P-ChIPS (Weller, 208 
Weller, Teare & Fristad, 1999) is a one-hour structured psychiatric interview for parents, and 209 
which has some psychometric evidence for children with ASD (Witwer, Lecavalier & Norris, 210 
2012).   211 
Child Symptom Inventory-4 (CSI-4). The CSI-4 (Gadow & Sprafkin, 2002) is a 212 
standardized screening measure which includes a MDD subscale. There are 97 items in the 213 
parent, and 77 in the teacher versions. Items are informant rated for frequency and severity of 214 
difficulties, and there is evidence of psychometric properties in ASD groups (Gadow, 215 
DeVincent & Schneider, 2008).  216 
Preschool Age Psychiatric Assessment (PAPA). The PAPA (Egger and Angold, 217 
2004) is a DSM-IV based semi-structured diagnostic interview for parents of toddlers. 218 
Interviews are conducted with parents who are asked about symptoms of disorders, including 219 
MDD during the last 3 months. 220 
Autism Comorbidity Interview-present and Lifetime (ACI-PL). The ACI-PL 221 
(Lainhart et al., 2003) is a semi-structured psychiatric interview about symptoms in the last 3 222 
months, or ever. It was developed from DSM-IV-TR with some evidence of psychometric 223 
properties in children with ASD demonstrated (Leyfer et al., 2006). 224 
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Mini International Neuropsychiatric Interview (MINI). The MINI (Sheehan et al. 225 
1998) is a short structured psychiatric diagnostic interview for clinical and research purposes 226 
based on DSM 1V and ICD 10. 227 
Self-report measures 228 
Child and Adolescent Symptom Inventory-4 (CASI-4). The CASI-4 (Gadow & 229 
Sprafkin, 2010) is a standardised self-report measure corresponding to DSM, in which items 230 
are rated 0 (never) to 3 (very often). It has a 10 item MDD subscale. The psychometric 231 
properties of the CASI-4 have been explored in children with ASD and found to be good, and 232 
ASD norms been published.  233 
Patient Health Questionnaire for Adolescents (PHQ-A). The PHQ-A (Johnson, 234 
Harris, Spitzer, & Williams, 2002) is a self-report screening measure with a 15 item MDD 235 
section. 236 
Beck Depression Inventory (BDI). The BDI (Beck & Steer, 1996) is a 21 item self-237 
report screening measure of depression symptoms during the previous week. The BDI is 238 
standardised, has been used in prevalence studies (Cederlund et al., 2010), and scoring 239 
thresholds are as follows: ≤ 10 no depression; 11–14 dysphoria; 15–19 dysphoria/depression; 240 
≥ 20-28 moderate depression; and ≥ 29 severe depression.  241 
Child Depression Inventory (CDI). The CDI (Kovacs, 1992) is a standardised 242 
screening measure of depression symptoms, with 3 response options across 27 items scores of 243 
≥ 19 suggest clinical depression.  244 
Hospital Anxiety and Depression Scale (HADS). The HADS (Snaith & Zigmond, 245 
1994) is a widely used 14 item self-report measure of mood symptoms for medical settings, 246 
with much accumulated psychometric evidence. 247 
The measures of depression in the studies reviewed were appropriately used given the 248 
ages of study participants. However, the measures developed for the general population could 249 
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have introduced some bias, possibly affecting accuracy of reported rates of depression. For 250 
example, although the Beck and Child Depression Inventories (BDI and CDI), the SCID, the 251 
HADS and the KSADS, have an established evidence base for their psychometric properties 252 
in the general population, reliability and validity are not established for individuals with HF 253 
ASD.  The CSI, the ACI-PL and the CASI-4, do have evidence of reliability and validity in 254 
individuals with ASD. However these measures are not depression specific, but rather have a 255 
depression subscale, limiting the amount of clinical detail that can be gathered on depression 256 
symptoms.     257 
Study Findings: rates of depression 258 
Informant report 259 
Informant report current rates of MDD in children are shown in Table 5. Rates of 260 
MDD using generic mental health measures with a depression subscale were between 2.5% 261 
and 29%. Rates of MDD calculated using measures with psychometric evidence for ASD 262 
groups were lower: including 15.8% on the Autism Co-morbidity Interview (Mazefsky et al., 263 
2011), and between 0% and 6.2% on the Child Symptom Inventory (Gadow et al., 2005).  264 
Self-report   265 
Self-reported rates of depression are shown in Table 6. MDD was 47.1% measured on 266 
the CASI, a generic child measure with a depression subscale (Bitsika & Sharpley, 2015). 267 
Rates were lower using depression specific screening measures. 29% of children scored 268 
above the suggested clinical cut off on the Child Depression Inventory (Vickerstaff et al, 269 
2007), while 35% of adults self-reported rates of depression above the clinical cut point on 270 
the Beck Depression Inventory (Crane et al, 2011). However, only 1% of adults scored within 271 
the severe range (scoring ≥ 30 on the BDI) (Cederlund et al, 2010), and when the Beck 272 
Depression Inventory was used in conjunction with, (the Mini International Neuropsychiatric 273 
Interview) only 4% had MDD (Gillberg et al, 2015).  274 
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Tables 5 and 6 around here 275 
Discussion 276 
Rates of depression identified 277 
Rates of depression in people with HF ASD varied widely across studies, from 1% to 278 
47.1%. Most rates for people with HF ASD were higher than the general population 279 
prevalence rates of 2.5% to 10.7% (NSDUH, 2013; Spiers et al, 2012). However, confidence 280 
in the validity of comparing these rates of MDD in people with HF ASD to general 281 
population prevalence rates, is compromised by a number of factors related to 282 
methodological aspects of the studies.  283 
Methodological aspects of the studies 284 
Only three studies in the review used measures with some psychometric validity for 285 
people with HF ASD (the ACI-PL, CSI and the CASI). There is therefore increased 286 
confidence in the validity of their reported rates of MDD from studies using these measures 287 
(between 15.8% and 47%) (Bitsika & Sharpley, 2015; Mazefsky et al., 2011). Nevertheless, 288 
these measures are not depression specific, but rather are generic with a depression subscale. 289 
This may influence reported rates for example, the generic Child Behaviour Checklist 290 
(CBCL) has some limitations in case recognition, and rates of depression do vary depending 291 
on the assessment measures used (Gjevik et al., 2015; Reijnders, Ehrt, Weber, Aarsland & 292 
Leentjens et al., 2008). The remaining studies measured depression using assessments and 293 
severity thresholds based on general population norms, which are not necessarily valid for 294 
people with HF ASD (Magnuson & Constantino, 2011). Measures of depression developed 295 
for the general population may not accurately capture the presentation of depression in HF 296 
ASD, and evidence of psychometric properties with people with ASD was often not available 297 
(Stewart et al., 2006).  298 
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The seemingly high rates of depression in some of the studies reviewed may also 299 
result from the relatively small number of participants and select samples used. This is in 300 
contrast to the large scale, and demographically representative epidemiological studies on 301 
which general population prevalence rates of depression are based.  Where studies recruit 302 
participants from clinical services (as the studies reviewed predominately did), levels of co-303 
existing conditions are expected to be higher compared to those from community settings 304 
(Reijnders et al., 2008). Similarly, medication and comorbidities including physical 305 
conditions are confounders with the potential to affect reported rates of depression, but were 306 
not always described in studies. 307 
Clinical Implications 308 
Knowledge of the rates of depression in people with HF ASD facilitates clinicians, 309 
managers and commissioners planning services and allocating resources appropriately. UK 310 
National Institute for Health and Care Excellence (NICE) (2009) guidance advocates the use 311 
of validated measures for assessment and evaluation of depression interventions. This is 312 
currently difficult to implement for people with HF ASD, given the lack of measures of 313 
depression psychometrically validated for this group. This may mean clinicians find case 314 
recognition and proving treatment effectiveness difficult (Geurts, Stek & Comijs, 2016; 315 
Rosbrook & Whittingham, 2010). Further work developing a conceptualisation of depression 316 
specifically in relation to people with ASD, would facilitate deeper understanding of specific 317 
difficulties and the tailoring of treatment interventions for best support. 318 
Strengths and limitations of the review 319 
We think this is the first systematic review to investigate rates of depression in people 320 
with HF ASD. The review adds to existing knowledge by highlighting issues which may 321 
influence the magnitude of reported rates in research and clinical settings.  322 
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ASD and ID often co-exist, and it is debated whether depression may be relatively 323 
high in people with ID, due to social circumstances and being less responsive to treatment 324 
(APA, 2013; Cooper, Smiley, Morrison, Williamson & Allan, 2007; Jahoda et al., 2015; 325 
Tsakanikos et al., 2006). Therefore one limitation of the review is that studies reporting rates 326 
of depression in people with ID were excluded, so the findings will not necessarily generalize 327 
to individuals with ASD and ID.  328 
For this review the risk of bias was assessed using a measure that was adapted from 329 
validated tools. This adaptation may have compromised the reliability and validity of bias 330 
assessments.  331 
Recommendations for Future Research  332 
Prevalence studies of depression across national population samples of people with 333 
ASD are a future research priority. Systematic epidemiological surveys of individuals with 334 
ASD are rare, but feasible given a large and representative enough sample. For example, 335 
Brugha et al., (2011) examined the prevalence of ASD across a sample of 7461 community 336 
adults, though information about mental health conditions were not available, and it would be 337 
ideal to include a measure of depression in a such a future study. Autism research registry 338 
databases are more able to yield population estimates of depression than small clinical 339 
samples, or those derived from one geographical area (Baird et al., 2006; Brugha et al., 2011). 340 
Fewer adult studies were found reflecting the need for research beyond childhood (Magiati, 341 
Tay & Howlin, 2014). Consideration of the confounding effects of any medication would be 342 
important in future studies. 343 
Consolidation of findings to date on phenomenology and correlates of depression in 344 
people with HF ASD, would inform development of reliable and valid depression diagnostic 345 
and screening measures. Studies have found particular items on the BDI endorsed in ASD 346 
groups e.g. guilt, though some general population indicators may be less useful, for example 347 
15 
 
asking about social withdrawal given the overlap with ASD characteristics (Gotham, Unruh 348 
& Lord, 2014; Stewart et al, 2006). Further exploration of the relationship between 349 
depression and cognitive style e.g. a bias towards internal attributions, or less positive 350 
appraisal would inform such developments (Barnhill & Myles, 2001; Happe & Frith, 2006). 351 
Further exploration of the interaction between depression, core ASD characteristics and IQ, 352 
would facilitate case recognition and treatment planning in people with ID and ASD.  353 
In conclusion, rates of depression identified in studies reviewed varied widely. 354 
However, the rates should be interpreted cautiously given studies mainly recruited from 355 
clinical groups, had small numbers of participants and, given the limited choice of measures 356 
psychometrically validated for people with ASD, mainly used measures of depression 357 
developed for typically developing groups. Epidemiological studies of depression in ASD 358 
could inform service providers and influence decisions on resource allocation. Measures of 359 
depression psychometrically validated for people with ASD would be important for these 360 
studies, along with accurate case recognition and evaluation of treatment interventions.  361 
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Table 1. Inclusion and exclusion criteria  
 
 
 
 
 
 
 
 
 
 
 Inclusion criteria Exclusion criteria 
Population Individuals of all ages with HF ASD and without 
intellectual disability (FSIQ >/= 70)  
FSIQ<70 
Context Clinical and community None 
Condition Current major depressive disorder; severe or clinical 
depression with specified thresholds.  
Non-specific affective disorder; subclinical depression/dysthymia. 
Lifetime depression. No actual thresholds described in the paper. 
Design Empirical group studies Case studies, case series, reviews 
Measure Specific measures of depression; generic measures with a 
depression subscale; ICD or DSM  
Studies measuring presence of depression with one question e.g. ‘has 
anyone ever told you that you have/ your child has depression?’ 
22 
 
           Table 2. Bias rating chart for studies selected for the review 
1. Diagnosis of HF ASD 
1. A diagnosis of HF ASD was made  prior to the study – no details given on method; or a different test used to those listed below (see 3) 
2.  Individuals were recruited from an HF ASD research database. A diagnosis of HF ASD was made prior to the study using the methods below.  
3. A diagnosis of HF ASD was confirmed at the time of the study by standardised test including; or by a psychologist or psychiatrist and DSM or ICD.  
2. Assessment of depression 
1. Non standardised  
2. Depression subscale within a standardised generic measure 
3. Standardised depression specific assessment or clinical interview; or diagnosis of depression according to DSM or ICD by psychiatrist or 
psychologist     
3. Clear description of participants 
1. Key demographic information missing.  
2. Some descriptive characteristics included; or reference to where further details can be found is provided 
3. Key characteristics described including: mean age, age range, gender, comorbidity, medication, ethnicity 
4. Description of recruitment pool provided 
1. Recruitment pool is not described. 
2. Some detail provided 
3. Recruitment pool described including: geographical area, method of referral (e.g. self, database), setting (e.g. clinic or school)  
5. Reliability and validity of depression outcome measure in HF ASD populations 
1. No psychometric properties reported for HF ASD 
2. Some evidence of reliability and validity  
3. The measure is standardised for HF ASD populations 
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6. Measure of IQ 
1. None give 
2. IQ given or e.g. described as all being >70 or having Asperger 
3. IQ measured during study (using e.g. Wechsler Adult Intelligence Scale (WAIS), Wechsler Intelligence Scale for Children (WISC), Stanford-Binet) 
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Table 3. Characteristics of included studies 
Author Country Population  ASD N 
(male) 
Age (years) 
Mean (SD); range  
Mean FSIQ 
(SD); range 
Medication  Outcomes related to 
depression 
Green, Gilchrist, Burton & 
Cox (2000)  
UK Clinical referrals 20 (20) 13.75 (11–19) 92.15 (17.7); 71-141 10%  Psychosocial 
functioning 
Hill, Berthoz & Frith 
(2004) 
 
France and 
UK 
Support groups/ 
community centres  
27 (15) 35.07 (12.26); 
16-63 
HF ASD NR Emotion processing  
Gadow, DeVincent, 
Pomeroy & Azizian 
(2005) 
USA Developmental disability 
clinic 
284 (242)  8.3 (1.8) 6-12 92(22.2)  38% Psychiatric comorbidity 
Vickerstaff, Heriot, Wong, 
Lopes & Dossetor (2007) 
Australia Social skills training 22 (19) 11.86 (1.65) 
7-13 
105.41 (15.34); 
82–141 
NR Social skills  
 
Shtayermman (2008) USA Autism Websites; 
previous research 
participants 
10 (9) 19.7 (3) Asperger 89% Suicidal ideation; 
comorbidity  
Cederlund, Hagberg & 
Gillberg (2010) 
Sweden Neuropsychiatric clinic 71 (71) 21.8 (4.6) 16–36 103.8 (15.2) 18% Informant agreement 
Mattila et al. (2010) 
 
Finland Community 
& clinical  
50 (38) 12.7 (1.5); 
9–16 
>75 NR Psychiatric comorbidity 
Mukkades & Fateh (2010) Turkey Psychiatric clinic 37 (32) 10.9 (4.5) 
6-20 
116 (14) 90-139 NR Psychiatric comorbidity 
Witwer & Lecavalier 
(2010) 
USA University and 
psychiatry clinics; 
previous research 
participants, ASD groups  
61 (50) 
 
11.2 (3.8);  
6–17 
>70 
(n = 22) 
5% - 61% Psychiatric comorbidity 
Crane, Goddard & Pring 
(2011) 
UK National Autistic 
Society. 
Support groups / web 
pages 
28 (14) 41.57 (16.49) 
 
117.18 (13.47)  NR Autobiographical 
memory  
Mazefsy, Kao & Oswald 
(2011) 
USA Word of mouth /fliers in 
developmental disorder 
clinic 
38 (31) 12(2) 10-17 105(17); 
71-144 
42% Self-report measures 
25 
 
Joshi et al (2013) USA ASD clinic 63 (41) 29 (11); 18-63 104.4 (17.3); 
97% > 70 
60% Psychiatric comorbidity 
van Steensel, Bögels, & de 
Bruin (2013) 
Netherlands Outpatient mental health 
centre  
40 (36) 11.10 (2.82); 8–18  88%>70 NR Psychiatric comorbidity 
Hepburn, Stern, Blakeley-
Smith, Kimel & Reaven 
(2014) 
USA Participants in a CBT 
study 
42 (34) 
 
10.9 (1.8);  8-14 98.4 (15) 
63-129 
NR Psychiatric comorbidity 
Bitsika & Sharpley (2015) Australia Parent support 
group; schools  
70 (70) 10.9 (3.4); 
8-18 
FSIQ: 96.21 (14.23) No anti-
depressants 
Prevalence, severity 
and symptom profiles  
Gillberg, Helles, Billstedt 
& Gillberg, (2015) 
Sweden Neuropsychiatric clinic 50 (50) 30.2 (5.0); 23–43 FSIQ: 107.6 NR Psychiatric disorders 
20 years after ASD 
diagnosis 
Orinstein et al. (2015) USA and 
Canada 
Multiple hospital and 
university sites 
42 (38) 13.9 (2.7); 8-20 
 
VIQ: 105.5 (14.7); 
81–142 
NR Psychiatric 
comorbidity 
Russell et al. (2015) UK ASD clinic 474 (372) 30.59 (11.18)  Excluded those with 
suspected ID 
NR Psychiatric 
comorbidity 
Salazar et al. (2015) 
 
UK Primary care and ASD 
support group 
101 (57) 
 
6.7 (1); 4-9 >70 (n =44) NR Psychiatric 
comorbidity 
  NR: not reported 
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Table 4. Bias within studies 
 
Article 
Diagnosis of 
ASD 
Depression 
measure  
Description of 
participants 
Description of 
recruitment pool  
Reliability/ validity of 
depression measure in 
ASD 
Measure of IQ 
Green et al. (2000)       
Hill et al. (2004)       
Gadow et al. (2005)       
Vickerstaff et al. (2007)       
Shtayermman (2008)  
 
     
Cederlund et al. (2010) 
 
      
Mattila et al. (2010)       
Mukkades et al. (2010)       
Witwer et al. (2010)  
 
     
Crane et al. (2011)       
Mazefsky et al. (2011)       
Joshi et al (2013)       
van Steensel et al. (2013)       
Hepburn et al. (2014)       
Bitsika & Sharpley 
(2015) 
      
Gillberg et al. (2015)       
Orinstein et al. (2015)       
Russell et al. (2015)       
Salazar et al. (2015)       
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Low risk of bias Medium risk 
of bias 
High risk of bias  
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Table 5. Study findings: diagnostic interview or informant reported current rates of depression and measure used (parent reported unless stated otherwise) 
Author Age group 
Child/Adult (C/A)  
Rates of major depressive disorder  Measure 
Generic measures with a depression subscale 
Joshi et al (2013) A 31% (self and parent/ guardian report) Structured Clinical Interview for DSM-IV (SCID) 
Van Steensel et al. 
(2013) 
C 2.5%  Structured Clinical Interview for DSM-IV Childhood 
Disorders (KID SCID) 
Mattilla et al. (2010) C 6%  Schedule for Affective Disorders and Schizophrenia for 
School-Age Children-Present and Lifetime Version 
(KSADS-PL) 
Mukkades et al. 2010 C 29%  
Hepburn et al. (2014) C 14.3%  
Orinstein et al. (2015) C 7% 
Green et al. (2000) C 5%  Isle of Wight Semi structured Interview 
Gadow et al. (2005) C Parent rated: males (6.2%) females (2.4%)  
Teacher rated: males (2.9%) females (0%)  
Child Symptom Inventory-4 (CSI-4) 
Witwer et al. (2010) C 22.7% Children’s Interview for Psychiatric Symptoms (P-ChIPS) 
Salazar et al. (2015) C 18.8 % Preschool Age Psychiatric Assessment (PAPA) 
Measures of ASD Co-morbidity  
Mazefsky et al. (2011) C 15.8% Autism Comorbidity Interview-present and Lifetime (ACI-
PL) 
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Table 6. Study findings: self-reported current rates of depression and measure used  
 
 
Author Age group  Child/Adult 
(C/A) 
Clinical depression MDD Measure 
Generic measures with a depression subscale  
Bitsika & Sharpley (2015) C  47.1%  
 
Child and Adolescent Symptoms Inventory 
(CASI) 
Russell et al (2015) A 15.8% depressive episode  Hospital Anxiety and Depression Scale (and 
ICD 10) 
Shtayermman (2008) C  20% Patient Health Questionnaire for Adolescents 
Standardised depression specific measures    Beck Depression Inventory (BDI) 
 Hill et al. (2004) A 22.2% (scored >/=20) 
Cederlund et al. (2010) A 1% severe depression (scored =/>30) 
Crane et al. (2011) A 35% (scored >/= 20) 
Gillberg et al. (2015) 
 
A  4% BDI in combination with Mini International  
Neuropsychiatric Interview 
Vickerstaff et al. (2007) C  29% (scored >/= 19)   Child Depression Inventory 
